Clinical Trials
All Clinical Trials - Page 20 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06139419Phase 2Completed
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Thymosin-Alpha-1
- NCT05936151Phase 2Completed
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Retatrutide
- NCT05945420Phase 4Unknown
Adding Desmopressin to Tamsulosin for Treatment of BPH
Desmopressin
- NCT05959096Phase 1Completed
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
Retatrutide
- NCT05916560Phase 1Completed
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Retatrutide
- NCT05936138Phase 1Completed
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
Orforglipron
- NCT05929079Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Retatrutide
- NCT05929066Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Retatrutide
- NCT05950516Phase 3Unknown
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
Semaglutide
- NCT05812183Phase 4Withdrawn
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
Tirzepatide
- NCT05726227Phase 3Active Not Recruiting
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Semaglutide
- NCT05891587Phase 2Completed
Semaglutide Therapy for Alcohol Reduction - Tulsa
Semaglutide
- NCT05884255Phase 3Recruiting
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Octreotide
- NCT06354101N/AWithdrawn
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
Tirzepatide
- NCT06219330N/ACompleted
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
Ll-37
- NCT06497049Phase 1Completed
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
Semaglutide
- NCT05701241Phase 4Recruiting
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Octreotide
- NCT05877547Phase 2Completed
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
Semaglutide
- NCT05847283N/ARecruiting
DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT
Gonadorelin
- NCT05819138Phase 3Recruiting
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Semaglutide
- NCT06154486N/ACompleted
Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
Semaglutide
- NCT05925959N/ARecruiting
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Semaglutide
- NCT05922579N/ATerminated
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
Lanreotide
- NCT05895643Phase 2Completed
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Semaglutide
- NCT05882032Phase 1Completed
A Study of LY3502970 in Participants With Impaired and Normal Liver Function
Orforglipron
- NCT05888961N/ARecruiting
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
Ghrp-6
- NCT06120556N/ACompleted
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
Semaglutide
- NCT07104461N/ACompleted
Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
Ghrp-6
- NCT05833217N/ARecruiting
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Octreotide
- NCT05872620Phase 3Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Orforglipron
- NCT05869903Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Orforglipron
- NCT05894486Phase 2Unknown
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Octreotide
- NCT05756764N/AActive Not Recruiting
Anti-obesity Pharmacotherapy and Inflammation
Tirzepatide
- NCT05898321N/AUnknown
To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
Gonadorelin
- NCT06118008Phase 2Completed
A Study of HS-20094 in T2DM Participants
Semaglutide
- NCT05882045Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Retatrutide
- NCT05890976Phase 3Completed
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
Semaglutide
- NCT07644897Phase 2Recruiting
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Thymosin-Alpha-1
- NCT05866029N/ARecruiting
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Teriparatide
- NCT05965167Phase 1Completed
Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
Teriparatide
- NCT05702905Phase 4Unknown
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Semaglutide
- NCT05793450Phase 1Completed
Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
Mazdutide
- NCT06475586Phase 4Completed
Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT05832060N/AUnknown
Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia
Selank
- NCT05681299Phase 4Recruiting
Effects of GH and Lirglutide on AgRP
Liraglutide
- NCT06842758N/AActive Not Recruiting
Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures
Teriparatide
- NCT05835089N/AUnknown
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Kisspeptin
- NCT05760313Phase 2Completed
A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
Linaclotide
- NCT05841238Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Orforglipron
- NCT05774756Phase 3Active Not Recruiting
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Setmelanotide